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We have shown previously that interleukin-4 (IL-4) protects TS1ab cells from apoptosis, but
very little is known about the mechanism by which IL-4 exerts this effect. We found that Akt
activity, which is dependent on phosphatidylinositol 3 kinase, is reduced in IL-4-deprived
TS1ab cells. Overexpression of wild-type Akt or a constitutively active Akt mutant protects
cells from IL-4 deprivation-induced apoptosis. Readdition of IL-4 before the commitment
point is able to restore Akt activity. We also show expression and c-Jun N-terminal kinase 2
activation after IL-4 deprivation. Overexpression of the constitutively activated Akt mutant
in IL-4-deprived cells correlates with inhibition of c-Jun N-terminal kinase 2 activity. Finally,
TS1ab survival is independent of Bcl-2, Bcl-x, or Bax.
INTRODUCTION
Interleukin-4 (IL-4) is a pleiotropic cytokine, produced
predominantly by T cells, mast cells, and basophils,
that stimulates proliferation of T cells, B cells, and
mast cells (Seder et al., 1981; Howard et al., 1982;
Brown et al., 1987; Paul, 1991). The biological functions
of IL-4 are mediated via its binding to a specific cell
surface receptor. This widely distributed receptor con-
sists of two chains that are members of the type I
cytokine receptor superfamily (Cosman, 1993), a li-
gand-binding chain (IL-4Ra), and the common g
chain, which is shared with the IL-2, IL-7, IL-9, and
IL-15 receptors (Noguchi et al., 1993; Kondo et al., 1993,
1994; Russell et al., 1993, 1994; Giri et al., 1994; Kimura
et al., 1995). Treatment of cells with IL-4 induces var-
ious biological responses, including an increase in cell
proliferation and gene transcription. Some of these
responses are unique to IL-4, and some are also in-
duced by other cytokines. Although the receptors for
IL-4 and IL-2 have several features in common, be-
cause of the g chain receptor component, IL-4 evokes
responses that IL-2 does not (Morla et al., 1988; Lin et
al., 1995; Quelle et al., 1995).
Apoptotic cell death is a process that ultimately
leads to activation of endogenous nucleases that pro-
mote internucleosomal DNA degradation (Wyllie,
1980). Apoptosis can be induced by growth factor
deprivation (Duke and Cohen, 1986; Nun˜ez et al., 1990;
Williams et al., 1990), signaling via surface receptors
(Smith et al., 1989; Benhamou et al., 1990; Hasbold and
Klaus 1990), and exposure to drugs (Zubiaga et al.,
1992) or DNA-damaging agents (Waters, 1992). Cell
surface receptor-mediated mechanisms that control
apoptosis often act through a signal transduction sys-
tem involving the stimulation of the receptor, the ac-
tivation of protein kinase and phosphatase cascades,
and the release of second messengers to up-regulate or
suppress the transcription of specific genes.
Many components of the machinery that regulate
and execute programmed cell death have been iden-
tified (Nagata et al., 1997). In addition to the central
role of the caspase family of proteases and the Bcl-2
family of apoptosis regulators, recent reports have
suggested that c-Jun N-terminal kinases (JNK) may be
involved in controlling apoptosis (Kyriakis and
Avruch, 1996).
JNKs are activated by stimuli such as UV light (De`-
rijard et al., 1994), g-irradiation (Chen et al., 1995; Khar-
banda et al., 1995), protein synthesis inhibitors (Kyri-§ Corresponding author. E-mail address: arebollo@cnb.uam.es.
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akis et al., 1994), ceramide (Westwick et al., 1995), and
DNA-damaging drugs (Van Dam et al., 1995; Yu et al.,
1996), TNF and IL-1 (Sluss et al., 1994; Raingeaud et al.,
1995). JNK activity is also induced by mitogenic sig-
nals, including growth factors (Hibi et al., 1993; Min-
den et al., 1994), oncogenic Ras (De`rijard et al., 1994),
CD40 ligation (Sakata et al., 1995; Berberich et al.,
1996), and T cell activation signaling (Chen et al., 1996;
Su et al., 1994). Included among JNKs are the 46-kDa
JNK1 and the 55-kDa JNK2 isoforms (Hibi et al., 1993;
Kyriakis et al., 1994), which phosphorylate transcrip-
tion factors such as c-Jun, ATF-2, and Elk-1 (Gupta et
al., 1995; Karin, 1995; Whitmarsch et al., 1995). JNK
activation requires phosphorylation at the Thr and Tyr
residues by the dual-specificity kinases SEK1 or
MKK4, which are activated following phosphoryla-
tion. One potential function of JNKs appears to be the
initiation of programmed cell death, although JNK
pathway activation does not necessarily lead to apo-
ptosis; IL-3, erythropoietin, and thrombopoietin acti-
vate the Ras/MEKK1/SEK1/JNK pathway without
induction of apoptosis (Nagata et al., 1997).
The serine and threonine kinase c-Akt, also known
as Raca or protein kinase Ba (Bellacosa et al., 1991;
Coffer and Woodgett, 1991; Jones et al., 1991), is the
cellular homologue of the v-Akt oncogene. Akt is com-
posed of an N-terminal pleckstrin homology domain,
followed by a catalytic domain and a short C-terminal
tail. Akt is regulated by both phosphorylation and the
direct binding of PI3 kinase (PI3K) lipid products to
the pleckstrin homology domain of Akt (Konishi et al.,
1996). In addition, other PI3K-independent mecha-
nisms of Akt activation have been identified (Didi-
chenko et al., 1996; Franke et al., 1997; Klippel et al.,
1997). Akt is a mediator of growth factor-induced
survival and suppresses the apoptotic death of a num-
ber of cell types induced by a variety of stimuli, in-
cluding IL-2 and IL-3 deprivation, cell-cycle discor-
dance, loss of cell adhesion, and DNA damage
(Ahmed et al., 1997; Dudek et al., 1997; Kauffmann-Zeh
et al., 1997; Kennedy et al., 1997; Khwaja et al., 1997;
Kulik et al., 1997; Songyang et al., 1997).
In this study, we examined the role of Akt and JNK2
in apoptosis mediated by IL-4 deprivation of TS1ab
cells, and the relevance of these findings is discussed
in the context of apoptosis.
MATERIALS AND METHODS
Cells and Cultures
TS1ab is a lymphokine-dependent mouse T cell line stably trans-
fected with the a and b chains of the human IL-2R (Pitton et al.,
1993). The TS1ab double transfectant responds independently to
IL-2, IL-4, or IL-9. Cells were cultured in RPMI 1640 (Bio-Whittaker,
Verviers, Belgium) supplemented with 5% heat-inactivated FCS
(Life Technologies, Paisley, UK), 2 mM glutamine, 10 mM HEPES,
0.55 mM arginine, 0.24 mM asparagine, 50 mM 2-mercaptoethanol,
and 60 U/ml IL-4 or 5 ng/ml recombinant IL-2.
Lymphokines, Antibodies, Reagents, and Plasmids
Human recombinant IL-2 was provided by Roussel Uclaf (Paris,
France). Murine recombinant IL-4 or cultured supernatant of a HeLa
subline (H28) transfected with the pKCRIL-4.neo plasmid was used
as a source of murine IL-4. Mouse antipan Ras monoclonal antibody
(Ab3) was obtained from Oncogene Science (Cambridge, MA). Rab-
bit polyclonal anti-JNK1 and -JNK2 were from Santa Cruz Biotech-
nology (Santa Cruz, CA). Rabbit polyclonal anti-Akt has been pre-
viously described (Franke et al., 1995). Monoclonal anti-p85 PI3K,
-Bcl-2, -Bax, and -Bcl-x antibodies were from Transduction Labora-
tories (Lexington, KY). Peroxidase (PO)-conjugated goat anti-rabbit
or -mouse immunoglobulin antibody was provided by Dako
(Glostrup, Denmark). Wortmannin and histone H2B were from
Sigma Chemical Co. (St. Louis, MO), agarose-conjugated human
c-Jun-GST was obtained from Upstate Biotechnolgy (Lake Placid,
NY) and DEAE-dextran was from Pharmacia (Uppsala, Sweden).
Enhanced chemiluminiscence (ECL) reagent and g32P were pro-
vided by Amersham (Buckinghamshire, UK), and Capture-Tec
pHook-3 kit was obtained from Invitrogen (San Diego, CA). The
annexin-FITC kit was from Immunotech (Marseille, France).
Generation of dominant negative Akt (Akt K179 M), constitu-
tively active Akt (Myr-Akt), and wild-type (wt) Akt have been
previously described (Franke et al., 1995). In brief, constitutively
activated myr-Akt.HA was generated by addition of a N-terminal
src myristoylation signal to a construct encoding Akt.HA.
Transient Transfection
Transfections were performed using the DEAE-dextran method.
Cells in exponential growth (1 3 107) were washed in TS buffer (25
mM Tris HCl, pH 7.4, 137 mM NaCl, 5 mM KCl, 0.7 mM CaCl, 0.5
mM MgCl2, and 0.6 mM Na2HPO4) and resuspended in 0.5 mg/ml
DEAE-dextran in TS buffer containing 5 mg of the corresponding
plasmid and pHook-3. A total of 6.75 ml RPMI with 5% FCS were
added after 20 min incubation at room temperature. Cells were
incubated for 1 h at 37°C, centrifuged, and resuspended in 10 ml
RPMI with 5% FCS alone or supplemented with 60 U/ml IL-4. The
capture-Tec pHook-3 kit was used for isolation of transiently trans-
fected cells from a mixed population of transfected and nontrans-
fected cells.
Cell Cycle Analysis
Propidium Iodide Staining. A total of 2 3 105 cells were washed and
resuspended in PBS, permeabilized with 0.1% NP-40, and stained
with 50 mg/ml propidium iodide immediately before analysis. Sam-
ples were analyzed using an Epics XL flow cytometer (Coulter,
Miami, FL). Apoptosis was measured as the percentage of cells
present in the subG1 region of the fluorescence scale having a
hypodiploid DNA content.
Annexin Staining. A total of 4 3 105 cells were washed with ice-cold
PBS, diluted in ice-cold binding buffer, and stained with annexin
and propidium iodide. Samples were maintained on ice for 10 min
in the dark and then analyzed by flow cytometry.
In Vitro JNK Assay
Cells (1 3 107) were lysed in radioimmunoprecipitation assay buffer
(50 mM Tris HCl, pH 7.4, 1% NP-40, 0.25% Na deoxycholate, 150
mM NaCl, 1 mM EGTA, and protease inhibitors). Supernatants
were immunoprecipitated with anti-JNK1 or -JNK2 antibody, fol-
lowed by incubation with protein-A Sepharose beads. Immunopre-
cipitates were washed, mixed with 3 mg agarose-conjugated puri-
fied c-Jun-GST and 20 mM [g-32P]ATP in 30 ml kinase buffer (20 mM
HEPES, pH 7.6, 20 mM MgCl2, 100 mM sodium orthovanadate, and
20 mM b-glycerophosphate), and incubated at 30°C for 20 min. The
reaction was stopped with SDS-PAGE sample buffer and boiled for
5 min before loading onto a 10% acrylamide gel. The gel was dried
and exposed to x-ray film.
A. Cerezo et al.
Molecular Biology of the Cell3108
In Vitro Akt Kinase Assay
Cells (1 3 107) were lysed in lysis buffer (50 mM Tris HCl, pH 7.5,
1% NP-40, 150 mM NaCl, and 5 mM EDTA) with protease inhibitors
for 20 min at 4°C and centrifuged (13,000 rpm for 15 min at 4°C).
Supernatants were immunoprecipitated with anti-Akt antibody and
protein-A Sepharose beads were then added. Immunoprecipitates
were washed and the kinase assay carried in 30 ml Akt kinase buffer
(20 mM HEPES, pH 7.4, 10 mM MgCl2, and 10 mM MnCl2) contain-
ing 10 mCi [g-32P]ATP, 5 mM unlabeled ATP, and 1 mM DTT.
Histone H2B was added as exogenous substrate at a final concen-
tration of 0.01 mg/ml. After 20 min at room temperature, the kinase
assay was terminated by the addition of SDS-PAGE sample buffer
and boiled for 5 min before loading onto a 12.5% gel. The gel was
dried and exposed to x-ray film.
In Vitro PI3K Assay
Cells (1 3 107) were lysed in lysis buffer (137 mM NaCl, 20 mM Tris
HCl, pH 8, 1 mM MgCl2, 1 mM CaCl2, 1% NP-40, and 10% glycerol)
with protease and phosphatase inhibitors for 20 min at 4°C and
centrifuged (13,000 rpm for 10 min at 4°C). Supernatants were
precleared with protein-A Sepharose beads and immunoprecipi-
tated with anti-p85 PI3K antibody. Protein-A Sepharose was added
for 1 h at 4°C. Immunoprecipitates were then washed once with
PBS; once with 0.5 M LiCl and Tris HCl, pH 7.4; once with H2O; and
once with 10 mM Tris HCl, pH 7.4, 100 mM NaCl, and 1 mM EDTA.
The kinase assay was performed in a final volume of 50 ml with 15
mCi [g-32P]ATP, S-adenosine, and 20 mg l-a-phosphatidylinositol
for 20 min at 24°C and terminated with 100 ml 1 M HCl. The lipids
were extracted with 200 ml chloroform/methanol (1:1), washed with
80 ml methanol/1 M HCl (1:1), and separated by thin-layer chroma-
tography on silica gel 60 plates coated with 1% potassium oxalate.
Plates were developed in chloroform/methanol/4 M NH4OH (9:
7:2) and exposed to x-ray film.
Western Blot
Cells (2 3 106) were lysed in Laemmli sample buffer and protein
extracts separated by SDS-PAGE, transferred to nitrocellulose mem-
brane, blocked with 5% nonfat dry milk in TBS (20 mM Tris HCl, pH
7.5, 150 mM NaCl), and incubated with the primary antibody in
TBS/0.5% nonfat dry milk. Membranes were washed with 0.05%
Tween-20 in TBS and incubated with a PO-coupled second anti-
body. After washing, labeled proteins were developed using the
ECL system.
When stripping of blots was required, membranes were incu-
bated with 62.5 mM Tris HCl, pH 6.8, 2% SDS, and 0.1 M 2-mer-
captoethanol for 1 h at 56°C and washed extensively with TBS
before reblocking and probing.
RESULTS
Apoptosis in IL-4-deprived TS1ab Cells Correlates
with Up-regulation of JNK2 Expression
TS1ab cells proliferate in the presence of IL-2, IL-4, or
IL-9. When IL-4-maintained cells are deprived of lym-
phokine, they undergo apoptosis as estimated by flow
cytometry (Figure 1A). As soon as 2 h after IL-4 with-
drawal, 6% of cells were apoptotic, reaching ;32% at
24 h, whereas control cells maintained in the presence
of IL-4 showed no apoptosis. Similar results were
obtained when the percentage of apoptotic cells was
estimated by annexin staining (Figure 1B). The com-
mitment point for apoptosis was 4–6 h (our unpub-
lished results). It was thus of interest to determine
whether induction of apoptosis by IL-4 deprivation
could modify the expression of JNKs, apoptosis-re-
lated molecules, and Akt kinase, a molecule that is
involved in apoptosis prevention as well as to Bcl-2.
The protein level of JNK1, JNK2, and Akt after IL-4
deprivation of TS1ab cells is shown in Figure 2A.
JNK1 expression showed no difference throughout the
starvation period analyzed compared with IL-4-stim-
ulated control cells. Similarly, control IL-4-cultured or
-deprived cells showed constant Akt expression
throughout the starvation period analyzed. Interest-
ingly, JNK2 expression was up-regulated after IL-4
deprivation; maximum expression was observed 4–8
h after IL-4 withdrawal, and disappeared almost com-
pletely 12 h after deprivation. Unaltered Ras expres-
sion was shown for all conditions as an internal pro-
tein loading control. These results show that in TS1ab
Figure 1. IL-4 deprivation induces apoptosis of TS1ab cells. (A)
Cells (2 3 105) were cultured in the presence or absence of IL-4 (60
U/ml) for 24 h. At different times, cells were harvested and ana-
lyzed for the percentage of apoptosis. Cells were permeabilized,
stained with propidium iodide, and analyzed for DNA staining
using fluorescence flow cytometry. The zero time point corresponds
to control cells cultured in IL-4. Error bars represent 6 SD from
three independent experiments. Apoptosis was measured as cells
present in the subG1 region of the fluorescence scale and having a
hypodiploid DNA content. (B) Cells were treated as in A, diluted in
ice-cold binding buffer, stained with annexin and propidium iodide,
and maintained on ice for 10 min in the dark. Samples were ana-
lyzed by flow cytometry.
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cells, IL-4 deprivation modifies JNK2 expression,
whereas JNK1 and Akt expression are unaffected.
The TS1ab cell line expressed the antiapoptotic pro-
tein Bcl-2 upon IL-2 stimulation, whereas IL-4-medi-
ated growth proceeds in the absence of Bcl-2 (Figure
2B) and Bax expression (our unpublished results).
Bcl-x and Bax levels were unaltered throughout the
IL-4 starvation period analyzed. This suggests that
IL-4 deprivation-induced apoptosis proceeds along
pathways that do not involve changes in Bcl-x or Bax
expression.
IL-4 Deprivation-induced Apoptosis Correlates with
Reduction of Akt and PI3K and Induction of JNK2
Activity
To examine the possible involvement of Akt, PI3K,
and JNKs in IL-4 deprivation-induced apoptosis, we
measured JNK1, JNK2, PI3K, and Akt kinase activity
in IL-4-stimulated and IL-4-deprived TS1ab cells. Akt
was immunoprecipitated with a specific antibody at
various time points after IL-4 deprivation, and the
kinase activity in the immunoprecipitates was mea-
sured using [g-32P]ATP and H2B as substrate. Akt
activity was detected in IL-4-cultured control cells.
Down-regulation of Akt activity was time dependent;
2 h after lymphokine deprivation, Akt activity was
inhibited and was almost undetectable 12 h after IL-4
withdrawal (Figure 3A). To ensure equal protein load-
ing, Akt activity was separated in SDS-PAGE, trans-
ferred to nitrocellulose, and probed with anti-Akt an-
tibody.
PI3K activity was determined in a-p85 PI3K immu-
noprecipitates of control or IL-4-deprived cells (Figure
3A). PI3K activity was detected in IL-4-maintained
cells, and decreased gradually throughout the IL-4
starvation period analyzed. The lowest level of activ-
ity was detected 12 h after deprivation.
Because Akt activity was reduced 2 h after IL-4
deprivation, it was of interest to know whether read-
dition of IL-4 after Akt activity down-regulation and
before the commitment point would be able to restore
Akt activity. Ts1ab cells were deprived of IL-4 for 3 h
and then IL-4 was added to the culture medium. Akt
activity was immunoprecipitated before and after IL-4
readdition and the kinase activity measured using
[g-32P]ATP and H2B as substrate (Figure 3B). IL-4-
cultured control cells showed Akt activity. Two hours
after lymphokine deprivation, Akt activity was de-
creased. Interestingly, readdition of IL-4 after 3 h of
starving restored Akt activity. As internal control of
protein loading, Akt activity was separated in SDS-
PAGE, transferred to nitrocellulose, and probed with
anti-Akt antibody.
JNK was immunoprecipitated with anti-JNK1 or
-JNK2-specific antibodies at various time points after
IL-4 deprivation. The kinase activity in the immuno-
precipitates was measured using [g-32 P]ATP and pu-
rified c-jun-GST fusion protein. JNK1 activity was al-
Figure 2. Time course of JNK1, JNK2, Akt, Ras, Bcl-2, Bcl-x, and
Bax expression in IL-4-deprived cells. (A) Control or IL-4-deprived
cells (2 3 106) were harvested at different time points, lysed, and
protein extracts separated in SDS-PAGE. Proteins were transferred
to nitrocellulose and probed sequentially with anti-JNK1, -JNK2,
-Akt, and -Ras antibody, the last as an internal protein loading
control. Protein bands were detected using the ECL system. Similar
results were obtained in three independent experiments. Molecular
mass markers are indicated. Densitometric analysis of JNK2 expres-
sion is shown below the blot. (B) TS1ab cells were stimulated by
IL-4 or deprived of lymphokine. At different time points, cells (2 3
106) were lysed and protein extracts separated, transferred to nitro-
cellulose, and probed with anti-Bcl-2, -Bax, and -Bcl-x. Cells main-
tained in IL-2 were used as a positive control. Protein bands were
detected using the ECL system. An internal control of homogeneous
Ras expression in all samples is shown. Similar results were ob-
tained in three independent experiments.
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most undetectable and remained constant throughout
the IL-4 deprivation time course analyzed (Figure 4).
A marked increase in JNK2 activity was detected as
soon as 2 h after IL-4 deprivation, reaching a plateau
at 4 h after starvation (Figure 4); kinase activity then
decreases and basal activity was detected 12 h after
IL-4 deprivation, as well as in control cells. As an
internal protein loading control, JNK2 kinase activity
was separated in SDS-PAGE, transferred to nitrocel-
lulose, and probed with anti-c-Jun antibody. In addi-
tion, c-jun levels were not altered during the starva-
tion period analyzed (our unpublished results).
Transient Expression of Constitutively Activated
Akt Prevents IL-4 Withdrawal-mediated Apoptosis
Because IL-4 deprivation in TS1ab cells correlates
with inhibition of Akt activity and apoptosis, we hy-
pothesized that transfection with a myr-Akt mutant or
wt Akt may activate a rescue pathway for apoptosis
mediated by IL-4 deprivation.
Cells transfected with myr-Akt, a constitutively ac-
tivated mutant, and deprived of IL-4 showed a reduc-
tion of ;45% in the fraction of apoptotic cells com-
Figure 3. IL-4 deprivation down-regulates Akt and PI3K activity.
(A) Cell lysates from control or IL-4-deprived cells (1 3 107) were
immunoprecipitated with anti-Akt antibody, and the Akt immuno-
complex assayed by phosphorylating H2B substrate in the presence
of [g-32P]ATP. Phosphorylated proteins were separated in SDS-
PAGE and visualized by autoradiography. As an internal control of
protein loading, Akt was separated by SDS-PAGE, transferred to
nitrocellulose, and probed with anti-Akt antibody. Similar results
were obtained in three independent experiments. Molecular mass
markers are shown. PI3K activity was immunoprecipitated with
anti-p85 PI3K antibody and determined by incorporation of
[g-32P]ATP into propidium iodide. Radiolabeled phosphatidylino-
sitol phosphate (PIP) was analyzed by thin-layer chromatography
on silica gel 60 plates and developed in chloroform/methanol/4 M
NH4OH (9:7:2). Dried plates were exposed to x-ray film. Migration
of PIP is indicated in the margin. Similar results were obtained in
three independent experiments. (B) Cells were IL-4 deprived for 3 h
and then IL-4 was added to the culture medium. Cell lysates from
control, IL-4-deprived, or IL-4-restimulated cells (1 3 107) were
immunoprecipitated with anti-Akt antibody and assayed as in A.
Akt was separated by SDS-PAGE, transferred to nitrocellulose, and
probed with anti-Akt antibody as internal control of protein load-
ing. Molecular mass markers are shown.
Figure 4. IL-4 deprivation induces JNK2 activation. Cell lysates
from control or IL-4-deprived cells (1 3 107) were immunoprecipi-
tated with anti-JNK1 or -JNK2 antibody. JNK1 and JNK2 immune
complexes were assayed by phosphorylating the c-Jun-GST sub-
strate in the presence of [g-32P]ATP. Phosphorylated proteins were
separated in SDS-PAGE and visualized by autoradiography. Den-
sitometric analysis of JNK2 activity is shown below the autoradiog-
raphy. As an internal control of c-Jun-GST protein loading in the
reaction, JNK2 kinase activity measured in the presence of
[g-32P]ATP was separated by SDS-PAGE, transferred to nitrocellu-
lose, and probed with anti-c-Jun antibody. Similar results were
obtained in three independent experiments. Molecular mass mark-
ers are shown.
Role of Akt and JNK2 in Apoptosis
Vol. 9, November 1998 3111
Figure 5.
A. Cerezo et al.
Molecular Biology of the Cell3112
Figure 5 (cont).
Role of Akt and JNK2 in Apoptosis
Vol. 9, November 1998 3113
pared with IL-4-deprived mock-transfected control
cells (Figure 5A. Similarly, when wt Akt-transfected
cells were deprived of IL-4, the fraction of apoptotic
cells was reduced to ;25% of those observed in
growth factor-deprived, mock-transfected cells. The
apoptosis detected in cells transfected with the domi-
nant negative Akt K179 M mutant in the absence of
IL-4 was comparable with that seen in mock-trans-
fected cells under the same culture conditions. The
frequency of apoptotic cells remained ;13–17% in all
transfected cells in the presence of IL-4, except for Akt
K179 M transfectants, which showed a slightly higher
level of apoptosis, even in the presence of IL-4. Similar
results were obtained when the percentage of apopto-
tic cells was estimated by annexin staining (Figure 5B).
It was of interest to determine whether constitutive
expression of Akt could inhibit JNK2 activation shown
after IL-4 deprivation. For this purpose, IL-4-deprived
cells were transiently transfected with the constitu-
tively activated myr-Akt mutant. Myr-Akt expression
in IL-4-deprived cells strongly blocked JNK2 activa-
tion (Figure 5C); similarly, overexpression of wt Akt
also significantly blocked JNK2 activation.
Expression of the transiently transfected Akt mu-
tants in TS1ab cells was confirmed by direct compar-
ison of Akt protein levels in transfected cells and in
mock-transfected controls (Figure 5C). Twenty-four h
posttransfection, Akt expression was increased in IL-
4-stimulated or IL-4-deprived cells transfected with
myr-Akt, wt Akt, and Akt K179 M compared with
mock transfectants. Unaltered Ras expression is
shown as an internal control of protein loading.
Figure 6. Effect of wortmannin on PI3K, Akt, and JNK2 activity.
Cell lysates from control or 100 nM wortmannin-treated cells
were immunoprecipitated with anti-Akt or -JNK2 antibody. Akt
or JNK2 immunocomplexes were assayed as described in Figures
3 and 4. Densitometric analysis of JNK2 activity is shown below
the autoradiography. PI3K activity was determined as described
in Figure 3. Migration of the PIP and molecular mass markers are
indicated. Similar results were obtained in three independent
experiments.
Figure 5. Overexpression of Akt induces JNK2 inhibition and pre-
vents apoptosis induced by IL-4 deprivation in TS1ab cells. (A)
Cells were transfected with the indicated constructs by the DEAE-
dextran method; maintained for 24 h in the presence or absence of
IL-4; and then selected, washed, permeabilized, and stained with
propidium iodide. Samples were analyzed by flow cytometry. The
most proximal region of the fluorescence scale (region E) represents
the subG1 region and corresponds to cells having a hypodiploid
DNA content (apoptotic cells). The percentages of apoptotic cells in
each sample are superimposed. Similar results were obtained in
three independent experiments. (B) Cells were treated as in A. After
selection, samples were diluted in ice-cold binding buffer, stained
with annexin and propidium iodide, and analyzed by flow cytom-
etry. Percentage of apoptotic cells is superimposed. (C) JNK2 acti-
vation and expression of wt Akt, Myr-Akt, or Akt K179 M in cells
maintained in the presence or absence of IL-4. Cells were transiently
transfected using the DEAE-dextran procedure and maintained 24 h
after transfection without lymphokine or in the presence of IL-4.
Cells were lysed and protein extracts immunoprecipitated with
anti-JNK2 antibody and assayed for JNK2 activity as in Figure 4, or
separated by SDS-PAGE, transferred to nitrocellulose, probed with
anti-Akt antibody and developed using the ECL system. Densito-
metric analysis of JNK2 activity is shown below the autoradiogra-
phy. The blot was stripped and probed with anti-Ras antibody as an
internal control of protein loading. Similar results were obtained in
three independent experiments. Molecular mass markers are
shown.
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Inhibition of PI3K Correlates with Reduction of Akt
Activity and JNK2 Activation
To test the role of PI3K in Akt activation and preven-
tion of apoptosis, we inhibited PI3K activity using the
inhibitor wortmannin. TS1ab cells maintained in the
presence of IL-4 were treated for different time periods
with wortmannin. Treatment of cells induced a re-
markable decrease in PI3K and Akt activity as com-
pared with untreated control cells, and wortmannin
treatment of IL-4 cultured cells increased JNK2 activ-
ity (Figure 6). Given that wortmannin induced reduc-
tion of Akt activity, it was of interest to analyze
whether PI3K activity inhibition induced apoptosis.
IL-4-maintained cells were treated with wortmannin
for different time periods and apoptosis was analyzed.
Apoptosis increased gradually with time, reaching
38% at 24 h (Figure 7A), which is similar to levels
observed after IL-4 deprivation for a similar period of
time (Figure 1). The percentage of apoptotic cells esti-
mated by annexin staining was similar to that ob-
served using propidium iodide staining (Figure 7B).
DISCUSSION
Using the lymphokine-dependent T cell line TS1ab as
a model, we analyzed the role of Akt and JNK in the
process of cell death promoted by IL-4 deprivation.
PI3K-dependent Akt activation is reduced in IL-4-de-
prived cells and readdition of IL-4 before the commit-
ment point is able to restore Akt activity. Apoptosis
induced by lymphokine withdrawal can be prevented
by overexpression of Akt. In addition, IL-4 starvation
correlates with induction of JNK2 activity.
Recent studies show that Akt activation by growth
factors depends on D3 phosphoinositides (Ahmed et
al., 1993; Burgering and Coffer 1995; Cross et al., 1995;
Downward, 1995, Franke et al., 1995; Alessi et al., 1997;
Stokoe et al., 1997), whose synthesis is catalyzed by
PI3K (Datta et al., 1996; Klippel et al., 1996; Carpenter
and Cantley, 1997). The PI3K inhibitor wortmannin
inhibited IL-4-mediated protection from apoptosis in
TS1ab cells. Our results suggest that PI3K and Akt
play a role in IL-4-mediated protection from apopto-
sis, because overexpression of a dominant negative
Akt mutant triggers apoptosis, even in the presence of
IL-4.
IL-3-dependent activation of Akt is mediated by PI3K
activation; consistent with results showing that Akt pro-
motes survival after IL-3 withdrawal (Songyang et al.,
1997), Akt also promotes survival after IL-4 deprivation
in TS1ab cells. Myr Akt, which is constitutively activated
independently of PI3K by localizing to the plasma mem-
brane, reduces the level of IL-4 deprivation-induced ap-
optosis by ;45%. wt aKT, which is activated by PI3K, is
less effective in preventing apoptosis mediated by IL-4-
deprivation, because PI3K activity is down-regulated in
the absence of IL-4. In addition, IL-4 is able to restore Akt
activity after 3 h of lymphokine deprivation. Akt is also
important for IGF-I-dependent survival of primary cer-
ebellar neurons (Dudek et al., 1997) and fibroblasts (Ku-
lik et al., 1997).
Cells dependent on growth factor usually undergo
apoptosis upon growth factor deprivation (Down-
ward, 1995). Two major components play a role in the
control of the cell death pathway: the Bcl-2 family
members, which block apoptosis, and the interleukin
Figure 7. Effect of the PI3K inhibitor wortmannin on the cell survival. (A) Cells cultured in the presence of IL-4 were supplemented with
100 nM wortmannin for different periods of time. After treatment, the percentage of apoptotic cells was analyzed. Cells were permeabilized,
stained with propidium iodide, and analyzed for DNA staining by flow cytometry. The most proximal region of fluorescence, region E,
represents the subG1 region, which corresponds to cells having a hypodiploid DNA content (apoptotic cells). Similar results were obtained
in three independent experiments. (B) Cells were treated as in A. After washing, samples were diluted in ice-cold binding buffer, stained with
annexin and propidium iodide, and analyzed by flow cytometry. Percentage of apoptotic cells is superimposed.
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convertin enzyme–like protease family, which exe-
cutes the apoptotic pathway. In the case of IL-2, a
signal transduced by Akt regulates Bcl-2 and c-Myc
expression; as a result, these molecules inhibit apopto-
sis and stimulate proliferation (Ahmed et al., 1997). In
TS1ab cells, IL-4-mediated growth and inhibition of
apoptosis proceed in the absence of Bcl-2 expression.
Consistent with our results, IL-3-dependent Akt acti-
vation uses a mechanism for cell survival that does not
involve Bcl-2 (Songyang et al., 1997). In addition, we
detected no significant change in the steady-state lev-
els of Bcl-x or Bax, either in IL-4-cultured cells or
following lymphokine deprivation. IL-4 also induces
protection from apoptosis in the myeloid progenitor
cell line 32D and in murine spleen B cells via the
insulin receptor substrate pathway (Zamorano et al.,
1996). Finally, activation of the antiapoptotic signaling
pathway PI3K/Akt protects fibroblasts from apoptosis
induced by UV-B light and promotes survival of su-
perior cervical neurons (Kulik et al., 1997; Philpott et
al., 1997).
JNK and stress-activated protein kinase have been
previously associated with the induction of apoptosis
(Chen et al., 1995; De`rijard et al., 1995; Van Dam et al.,
1995; Yu et al., 1996). In our cell model, IL-4 depriva-
tion-induced apoptosis correlates with JNK2 activa-
tion and up-regulation at the protein level. JNK acti-
vation does not necessarily lead to apoptosis;
however, IL-1, IL-3, erythropoietin, and thrombopoi-
etin also activate JNK and do not induce apoptosis
(Nagata et al., 1997).
Akt activation by growth factors is at least partially
dependent on Ras activation in some cell types
(Franke et al., 1995), and coexpression of activated
mutants of Ras stimulates Akt activity (Klippel et al.,
1996; Kauffmann-Zeh et al., 1997). The ability of Ras to
stimulate Akt is dependent on PI3K activation, placing
this enzyme downstream of Ras in this signaling path-
way. In IL-4-dependent T cell lines such as TS1ab–Ras
is not activated via the IL-4 receptor (Go´mez et al.,
1997).
Our results suggest that PI3K and Akt activity cor-
relates with cell survival through the IL-4 receptor.
PI3K and Akt inhibition caused by IL-4 deprivation or
wortmannin treatment also correlates with JNK2 acti-
vation and the ability of Myr-Akt to mediate survival
correlates with the inhibition of JNK2 activity.
Although many factor-dependent cell lines respond
to IL-4 with increased [3H]thymidine incorporation
into DNA, only a few cell lines have been successfully
adapted to growth in IL-4 alone. Among them, TS1ab
and LD8, two murine T cell lines described by our
group, can be propagated indefinitely in IL-4. The
findings presented here using an IL-4-dependent mu-
rine T cell line as a cellular model, provide new and
original insights into the mechanism by which IL-4
could regulate cell survival.
ACKNOWLEDGMENTS
We thank C. Mark for editorial assistance. The Department of
Immunology and Oncology was founded and is supported by the
Consejo Superior de Investigaciones Cientı´ficas and Pharmacia and
Upjohn.
REFERENCES
Ahmed, N.N., Franke, F., Bellacosa, A., Datta, K., Gonzalez-Portal,
M.E., Taguchi, T., Testa, J.R., and Tsichlis, P.N. (1993). The proteins
encoded by c-akt and v-akt differ in post-translational modifica-
tions, subcellular localization and oncogenic potential. Oncogene 8,
1957–1963.
Ahmed, N.N., Grimes, H.L., Bellacosa, A., Chan, T.O., and Tsichlis,
P.N. (1997). Transduction of interleukin-2 antiapoptotic and prolif-
erative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94,
3627–3632.
Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Gaffney, P.R.,
Reese, C.B., and Cohen, P. (1997). 3-Phosphoinositide-dependent
protein kinase 1 (PDK1) phosphorylates and activates the p7056
kinase in vivo and in vitro. Curr. Biol. 7, 261–269.
Bellacosa, A., Testa, J.R., Staal, S.P., and Tsichlis, P.N. (1991). A
retroviral oncogene, AKT, encoding a serine-threonine kinase con-
taining an SH2-like region. Science 254, 244–247.
Benhamou, L.E., Cazenave, P.A., and Sarthou, P. (1990). Anti-im-
munoglobulins induce death by apoptosis in WEHI-231 B lym-
phoma cells. Eur. J. Immunol. 20, 1405–1407.
Berberich, I., Shu, G., Siebelt, F., Woodgett, J.R., Kyriakis, J.M., and
Clark, E.A. (1996). Cross-linking CD40 on B cells preferentially
induces stress-activated protein kinases rather than mitogen acti-
vated protein kinases. EMBO J. 15, 92–101.
Brown, M.A., Pierce, J.H., Watson, C.J., Falcon, J., Ihle, J.N., and
Paul, W.E. (1987). B cell stimulatory factor-1/IL-4 mRNA is ex-
pressed by normal and transformed mas cells. Cell 50, 809–818.
Burgering, B.M., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in
phosphatydilinositol-3-OH kinase signal transduction. Nature 376,
599–602.
Carpenter, C.L., and Cantley, L.C. (1997). Phosphoinositide kinases.
Curr. Opin. Cell Biol. 8, 153–158.
Chen, Y.-R., Meyer, C.F., and Tan, T.H. (1996). Persistent activation
of c-Jun N-terminal kinase (JNK1) in gamma radiation-induced
apoptosis. J. Biol. Chem. 271, 631–634.
Chen, Y.R., Meyer, C.F., and Tan T.H. (1995). Persistent activation of
JNK1 in gamma irradiation-induced apoptosis. J. Biol. Chem. 27,
631–643.
Coffer, P.J., and Woodgett, J.R. (1991). Molecular-cloning and char-
acterization of a novel putative protein-serine kinase related to the
cAMP-dependent and protein-kinase-C families. Eur. J. Biochem.
201, 475–481.
Cosman, D. (1993). The hematopoietic receptor superfamily. Cyto-
kine 5, 95–106.
Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hem-
mings, B.A. (1995). Inhibition of glycogen sinthase kinase-3 by in-
sulin mediated by PKB. Nature 378, 785–789.
Datta, K., Bellacosa, A., Chan, T.O., and Tsichlis, P.N. (1996). Akt is
a direct target of the phosphatydilinositol 3 kinase. Activation by
growth factor, v-src and v-Ha-ras in Sf9 and mammalian cells.
J. Biol. Chem. 271, 30835–30839.
De`rijard, B., Hibi, M., Wu, Y.H., Barrett, T., Su, B., Deng, T., Karin,
M., and Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV
A. Cerezo et al.
Molecular Biology of the Cell3116
light and Ha-Ras that binds and phosphorylates the c-Jun activation
domain. Cell 76, 1025–1037.
Didichenko, S.A., Tilton, B., Hemmings, B.A., Ballmer-Hofer, K.,
and Thelen, M. (1996). Constitutive activation of the protein kinase
B and phosphorylation of the p47phox by a membrane-targeted
phosphoinositide 3-kinase. Curr. Biol. 6, 1271–1278.
Downward, J. (1995). Signal transduction. A target for PI(3) kinase.
Nature 376, 553–554.
Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Coo-
per, G.M., Segal, R.S., Kaplan, D.R., and Greenberg, M.E. (1997).
Regulation of neuronal survival by the serine-threonine protein
kinase Akt. Science 275, 661–665.
Duke, R.C., and Cohen, J.J. (1986). IL-2 addiction: withdrawal of
growth factor activates a suicide program in dependent T cells.
Lymphokine Res. 5, 289–299.
Franke, T.F., Kaplan, D.R., Cantley, L.C., and Toker, A. (1997).
Direct regulation of the Akt proto-oncogene product by phosphati-
dylinositol-3,4-bisphosphate. Science 275, 665–668.
Franke, T.F., Yang, S.Y., Chan, T.O., Datta, K., Kazlauskas, A.,
Morrison, D.K., Kaplan, D.R., and Tsichlis, P.N. (1995). The protein
kinase encoded by the akt proto-oncogene is a target of the PDGF-
activated phosphatydilinositol 3-kinase. Cell 81, 727–736.
Giri, J.G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K.,
Kumanki, S., Namen, A., Park, L.S., Cosman, D., and Anderson, D.
(1994). Utilization of the beta and gamma chains of the IL-2 receptor
by the novel cytokine IL-15. EMBO J. 13, 2822–2830.
Go´mez, J., Martı´nez-A., C., Fernandez, B., Garcia, A., and Rebollo,
A. (1997). Ras activation leads to cell proliferation or apoptotic cell
death upon IL-2 stimulation or lymphokine deprivation respec-
tively. Eur. J. Immunol. 27, 1610–1618.
Gupta, S., Campbell, D., De`rijard, B., and Davis, R.J. (1995). Tran-
scription factor ATF2 regulation by JNK signal transduction path-
way. Science 267, 389–393.
Hasbold, J., and Klaus, G.G.B. (1990). Anti-immunoglobulins anti-
bodies induce apoptosis in immature B cell Lymphomas. Eur. J. Im-
munol. 20, 1685–1690.
Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993).
Identification of an oncoprotein- and UV-responsive protein kinase
that binds and potentiates the c-Jun activation domain. Genes Dev.
7, 2135–2148.
Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K.,
Hanaoka, T., and Paul, W.E. (1982). Identification of a T cell derived
beta cell growth factor distinct from IL-2. J. Exp. Med. 155, 914–923.
Jones, P.F., Jakubowicz, T., Pitossi, F.J., Maurer, F., and Hemmings,
B.A. (1991). Molecular-cloning and identification of a serine threo-
nine protein-kinase of the 2nd-messenger subfamily. Proc. Natl.
Acad. Sci. USA 88, 4171–4175.
Karin, M. (1995). The regulation of AP1 activity by MAP kinases.
J. Biol. Chem. 270, 16483–16486.
Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C.,
Coffer, P., Downward, J., and Evan, G. (1997). Suppression of the
c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB.
Nature 385, 544–548.
Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacosa, A.,
Tsichlis, P.N., and Hay, N. (1997). The PI3-kinase/Akt signaling
pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701–713.
Kharbanda, S., Ran, R., Pandey, P., Shafman, T.D., Feller, S.M.,
Weichselbaum, R.R., and Kufe, D.W. (1995). Activation of the c-Abl
tyrosine kinase in the stress response to DNA-damaging agents.
Nature 376, 785–788.
Khwaja, A., Rodriguez-Viciana, P., Wennstorn, S., Warne, P.H., and
Downward, J. (1997). Matrix adhesion and Ras transformation both
activate a phosphoinositide 3-OH kinase and protein kinase B/Akt
cellular survival pathway. EMBO J. 16, 2783–2793.
Kimura, K., Leonard, W.J., Noguchi, M., and Russell, S.M. (1995).
Sharing of a common gamma chain by the IL-4, IL-2 and IL-7
receptor. Adv. Exp. Med. Biol. 385, 225–232.
Klippel, A., Kavanaugh, W.M., Pot, D., and Williams, L.T. (1997). A
specific product of phosphatidylinositol 3-kinase directly activates
the protein kinase Akt through its pleckstrin homology domain.
Mol. Cell. Biol. 17, 338–344.
Klippel, A., Reinhard, C., Kavanaugh, W.M., Apell, G., Escobedo,
M.A., and Williams, L.T. (1996). Membrane localization of phospha-
tydilinositol 3 kinase is sufficient to activate multiple signal-trans-
ducing kinase pathways. Mol. Cell. Biol. 16, 4117–4127.
Kondo, M., Takeshita, H., Higuchi, M., Nakamura, M., Sudo, T.,
Nishikawa, S., and Sugamura, K. (1994). Functional participation of
the IL-2R gamma chain in IL-7 receptor complexes. Science 263,
1453–1454.
Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S.,
Arai, K., and Sugamura, K. (1993). Sharing the IL-2 receptor gamma
chain between receptors for IL-2 and IL-4. Science 262, 1874–1877.
Konishi, K., Matsuzaki, H., Tanaka, M., Ono, Y., Tokunaga, C.,
Kuroda, S., and Kikkawa, U. (1996). Activation of Rac-protein kinase
by heat shock and hyperosmolarity stress through a pathway inde-
pendent of PI3 kinase. Proc. Natl. Acad. Sci. USA 93, 7639–7644.
Kulik, G., Klippel, A., and Weber, M.J. (1997). Antiapoptotic signal-
ling by the insulin-like growth factor I receptor, phosphatidylinosi-
tol 3-kinase, and Akt. Mol. Cell. Biol. 17, 1595–1606.
Kyriakis, J.M., and Avruch, J. (1996). Protein kinase cascades acti-
vated by stress and inflammatory cytokines. Bioessays 18, 567–577.
Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubi, E.A., Ah-
mad, M.F., Avruch, J., and Woodgett, J.R. (1994). The stress-acti-
vated protein kinase subfamily of the c-Jun kinases. Nature 369,
156–160.
Lin, J.-X., et al. (1995). The role of pleiotropy and redundancy by
IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2, 331–339.
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., De`rijard, B.,
Davis, R.J., Johnson, G.L., and Karin, M. (1994). Differential activa-
tion of ERK and JNK mitogen-activated protein kinases by Raf-1
and MEKK. Science 266, 1719–1723.
Morla, A.O., Schreurs, J., Miyajima, A., and Wang, J.Y.J. (1988).
Hematopoietic growth factors activate the tyrosine phosphorylation
of distinct sets of proteins in interleukin-3-dependent murine cell
lines. Mol. Cell. Biol. 8, 2214–2218.
Nagata, Y., Nishida, E., and Todokono, K. (1997). Activation of JNK
signaling pathway by erythropoietin, thrombopoietin and IL-3.
Blood 89, 2664–2669.
Noguchi, M., Nakamura, Y., Russell, S.M., Ziegler, S.F., Tsang, M.,
Cao, X., and Leonard, W.J. (1993). IL-2 receptor gamma chain: a
functional component of the IL-7 receptor. Science 262, 1877–1880.
Nun˜ez, G., London, L., Hockenbery, D., Alexander, M., McKearn,
J.P., and Korsmeyer, S.J. (1990). Deregulated Bcl-2 gene expression
selectively prolongs survival of growth factor-deprived hemopoi-
etic cell line. J. Immunol. 144, 3602–3610.
Paul, W.E. (1991). IL-4: a multifunctional regulator of immunity and
inflammation. J. Cancer Res. 82, 1458–1459.
Philpott, K.L., McCarthy, M.J., Klippel, A., and Rubin, L.L. (1997).
Activated PI3 Kinase and Akt kinase promote survival of superior
cervical neurons. J. Cell. Biol. 139, 809–815.
Role of Akt and JNK2 in Apoptosis
Vol. 9, November 1998 3117
Pitton, C., Rebollo, A., Van Snick, J., Theze, J., and Garcı´a, A. (1993).
High-affinity and intermediate-affinity forms of the human interleu-
kin 2 receptor, expressed in an interleukin 9-dependent murine T
cell line, deliver proliferative signals via differences in their trans-
duction pathways. Cytokine 5, 362–371.
Quelle, F.W., et al. (1995). Cloning of murine Stat6, Stat proteins that
are tyrosine phosphorylated in response to IL-4 and IL-3 but are not
required for mitogenesis. Mol. Cell. Biol. 15, 3336–3343.
Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch,
R.J., and Davis, R.J. (1995). Pro-inflammatory cytokines and envi-
ronmental stress cause p38 mitogen-activated protein kinase activa-
tion by dual phosphorylation on tyrosine and threonine. J. Biol.
Chem. 270, 7420–7426.
Russell, S.M., Johnston, J.A., Noguchi, M., Kawamura, M., Bacon,
C.M., Friedman, M., Berg, M., McVicar, D.W., Witthunn, B.A., and
Silvennoinen, O. (1994). Interaction of IL-2R beta and gamma chains
with Jak1 and Jak3. implications for XSCID and XCID. Science 266,
1042–1045.
Russell, S.M., Keegan, A.D., Harada, N., Nakamura, Y., Noguchi,
M., Leland, P., Friedmann, M.C., Miyajima, A., Puri, R.K., and Paul,
W.E. (1993). IL-2R gamma chain, a functional component of the IL-4
receptor. Science 262, 1880–1883.
Sakata, N., Patel, H.R., Terada, N., Aruffo, A., Johnson, G.L., and
Gelfond, E.W. (1995). Selective activation of c-Jun kinase mitogen-
activated protein kinase by CD-40 on human B cells. J. Biol. Chem.
270, 30823–30828.
Seder, R.A., Paul, W.E., Ben-Sasson, S.Z., LeGross, G.S., Kagey-
Sobotka, A., Finkelman, F.D., Pierce, J.H., and Plant, M. (1981).
Production of IL-4 and other cytokines following stimulation of mas
cell lines and in vivo mast cells/basophils. Int. Arch. Allergy. Appl.
Immunol. 94, 137–140.
Sluss, H.K., Barrett, T., De`rijard, B., and Davis, R.J. (1994). Signal
transduction by tumor necrosis factor mediated by JNK protein
kinases. Mol. Cell. Biol. 14, 8376–8384.
Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J., and Owen,
J.J.T. (1989). Antibodies to CD3/T cell receptor complex induce cell
death by apoptosis in immature T cell in thymic culture. Nature 337,
181–184.
Songyang, Z., Baltimore, D., Cantley, L.C., Kaplan, D.R., and
Franke, T.F. (1997). Interleukin 3-dependent survival by the Akt
protein kinase. Proc. Natl. Acad. Sci. USA 94, 11345–11350.
Stokoe, D., Stephens, L.R., Copeland, T., Gaffney, P.R., Reese, C.B.,
Painter, G.F, Holmes, A.B., McCormick, F., and Hawkins, P.T.
(1997). Dual role of phosphatidylinositol 3,4,5-triphosphate in the
activation of protein kinase B. Science 277, 567–570.
Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben-Neriah,
Y. (1994). JNK is involved in signal integration during co-stimula-
tion of T lymphocytes. Cell 77, 727–736.
Van Dam, H., Wilhem, D., Herr, I., Steffen, A., Herlich, P., and
Angel, P. (1995). ATF-2 is preferentially activated by stress-activated
protein kinases to mediate c-jun induction in response to genotoxic
agents. EMBO J. 14, 1798–1811.
Waters, R.L. (1992). Radiation-induced apoptosis in a murine T-cell
hybridoma. Cancer Res. 52, 883–890.
Westwick, J.K., Bielawska, A.E., Dbaibo, G., Hannun, Y.A., and
Brenner, D.A. (1995). Ceramide activates the stress-activated protein
kinases. J. Biol. Chem. 270, 22689–22692.
Whitmarsch, A.J., Shore, P., Sharroks, A.D., and Davis, R.J. (1995).
Integration of MAP kinase signal transduction pathways at the
serum response element. Science 269, 403–407.
Williams, G.T., Smith, C.A., Spooncer, E., Drexter, T.M., and Taylor,
D.R. (1990). Haemopoietic colony-stimulating factors promote cell
survival by suppressing apoptosis. Nature 343, 76–79.
Wyllie, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is
associated with endogenous nuclease activation. Nature 284, 555–
556.
Yu, R., Shtil, A.A., Tan, T.H., Roninson, I.B., and Kong, A.N.T.
(1996). Adriamicyn activates c-jun N-terminal kinase in human
leukemia cells. A relevance to apoptosis. Cancer Lett. 107, 73–81.
Zamorano, J., Wang, H.Y., Wang, L.M., Pierce, J.H., and Keegan,
A.D. (1996). IL-4 protects cells from apoptosis via the insulin recep-
tor substrate pathway and a second independent signaling path-
way. J. Immunol. 157, 4926–4934.
Zubiaga, A.M., Mun˜oz, E., and Huber, B.T. (1992). IL-4 and IL-2
selectively rescue Th cell subsets from glucocorticoid-induced apo-
ptosis. J. Immunol. 149, 107–112.
A. Cerezo et al.
Molecular Biology of the Cell3118
